Resveratrol Analogues as Selective Estrogen Signaling Pathway Modulators: Structure-Activity Relationship

Area of Science:

• Pharmacology
• Molecular Biology
• Medicinal Chemistry

Background:

• Resveratrol, a phytoalexin from plants like grapes, exhibits anticancer, chemopreventive, antioxidant, and phytoestrogenic activities.
• Its interaction with estrogen receptors (ERs) is established, acting as a mixed agonist/antagonist, with hydroxyl groups being crucial for activity.
• Existing research presents some conflicting results regarding its phytoestrogenic effects.

Purpose of the Study:

• To investigate the role of hydroxyl and methoxy groups in resveratrol analogues on estrogen receptor modulation.
• To identify specific resveratrol derivatives with potential selective estrogen receptor modulator (SERM) activity.

Main Methods:

• Assayed 11 resveratrol analogues with varying hydroxyl and methoxy group substitutions.
• Utilized recombined estrogen receptors and estrogen-dependent cell lines (MCF-7, Ishikawa).
• Performed in silico molecular docking studies to complement experimental findings.

Main Results:

• Resveratrol and specific analogues (3,4,4'5'-tetrahydroxystilbene, 3,3',4,5,5'-pentahydroxystilbene, 3,3',4,4',5,5'-hexahydroxystilbene) demonstrated potential as selective estrogen receptor modulators.
• Hydroxyl group positions were critical for interaction with estrogen receptors.

Conclusions:

• The substitution patterns of hydroxyl and methoxy groups significantly influence resveratrol's interaction with estrogen receptors.
• Certain resveratrol analogues exhibit promising selective estrogen receptor modulator properties, warranting further investigation.